Literature DB >> 11579192

Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial.

R Ashcroft1, B Fraser, M Kerr, Z Ahmed.   

Abstract

People with learning disability sometimes display challenging behaviour. This can be managed by use of antipsychotic medication or behavioural therapy or both. There is no solid evidence, however, that these therapies are safe and effective. A randomised controlled trial of antipsychotic medication has been proposed to deliver such evidence. However, this presents difficult issues in the ethics of research with learning disabled people. In particular, is a trial the most efficient and fairest way to evaluate practice in this area? This paper reviews the clinical situation, gives the rationale for the trial, and analyses the ethical arguments for and against such a trial.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Substances:

Year:  2001        PMID: 11579192      PMCID: PMC1733459          DOI: 10.1136/jme.27.5.338

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  15 in total

1.  Giving medicine a fair trial. Trials should not second guess what patients want.

Authors:  R Ashcroft
Journal:  BMJ       Date:  2000-06-24

2.  Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials.

Authors:  J Brylewski; L Duggan
Journal:  J Intellect Disabil Res       Date:  1999-10

3.  An argument against research on people with intellectual disabilities.

Authors:  S D Edwards
Journal:  Med Health Care Philos       Date:  2000

Review 4.  Ethical challenges in the conduct of research involving persons with mental retardation.

Authors:  R I Freedman
Journal:  Ment Retard       Date:  2001-04

Review 5.  Effectiveness of antipsychotic medication in people with intellectual disability and schizophrenia: a systematic review.

Authors:  L Duggan; J Brylewski
Journal:  J Intellect Disabil Res       Date:  1999-04

6.  Akathisia in neuroleptic medicated mentally handicapped subjects.

Authors:  S Ganesh; J M Murti Rao; V A Cowie
Journal:  J Ment Defic Res       Date:  1989-08

7.  Review of states' practices on the use of psychotropic medication.

Authors:  C Rinck; J Guidry; C F Calkins
Journal:  Am J Ment Retard       Date:  1989-05

8.  Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.

Authors:  J E Kalachnik; S R Harder; P Kidd-Nielsen; E Errickson; M Doebler; R L Sprague
Journal:  Psychopharmacol Bull       Date:  1984

9.  Behavioral problems and medication utilization.

Authors:  D C Harper; J S Wadsworth
Journal:  Ment Retard       Date:  1993-04

10.  Psychiatric and behaviour disturbance in mental handicap.

Authors:  W I Fraser; I Leudar; J Gray; I Campbell
Journal:  J Ment Defic Res       Date:  1986-03
View more
  1 in total

1.  Engaging Caregivers in the Treatment of Youth with Complex Developmental and Mental Health Needs.

Authors:  Ahrang Yoo; Monique Kim; Melissa M Ross; Angela Vaughn-Lee; Beverly Butler; Susan dosReis
Journal:  J Behav Health Serv Res       Date:  2018-07       Impact factor: 1.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.